Clal Biotechnology reported ILS6.66M in Current Liabilities for its fiscal quarter ending in December of 2023.





Current Liabilities Change Date
aTyr Pharma USD 15.68M 148K Sep/2025
Clal Biotechnology ILS 6.66M 3.75M Dec/2023
Compugen USD 20.28M 300K Sep/2025
RedHill Biopharma USD 22.29M 64K Jun/2025